A comparative study of CSF neurofilament light and heavy chain protein in MS

Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression

(2012) R. Tortelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis

(2012) K. B. Boylan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

The neurofilament light chain is not stable in vitro

(2011) Marleen J.A. Koel-Simmelink et al.   ANNALS OF NEUROLOGY

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis

(2011) J. Kuhle et al.   NEUROLOGY

Evidence for acute neurotoxicity after chemotherapy

(2010) Axel Petzold et al.   ANNALS OF NEUROLOGY

A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein

(2010) Jens Kuhle et al.   JOURNAL OF NEUROIMMUNOLOGY

A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect

(2010) Ching-Hua Lu et al.   JOURNAL OF NEUROSCIENCE METHODS

EFNS guidelines on disease-specific CSF investigations

(2009) F. Deisenhammer et al.   EUROPEAN JOURNAL OF NEUROLOGY

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

(2009) C. E. Teunissen et al.   NEUROLOGY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY